Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $66 at RBC Capital

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $66 at RBC Capital

Biohaven Pharma (BHVN) Misses Q3 EPS by 4c

November 12, 2024 4:09 PM EST

Biohaven Pharma (NYSE: BHVN) reported Q3 EPS of ($1.74), $0.04 worse than the analyst estimate of ($1.70).

For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.

... More